• Our Vision is to improve healthcare as a global provider of innovative and reliable diagnostic tests.
  • Our Mission is to identify and develop novel patentable diagnostic markers and technologies which can be commercialised to meet clinical needs, both in the laboratory and at the point of care.
  • We will collaborate with partners, create branded products and identify complementary businesses which support our objective of continuing to grow as a respected and profitable healthcare company.
  • Our Values include meeting all current and future regulatory, quality and environmental standards appropriate for our industry and the countries in which we operate.
 

Anti-CCP ELISA

The measurement of anti-CCP antibodies has become the method    of choice in the accurate diagnosis    of Rheumatoid Arthritis.
 
Assays using the second-generation CCP2 peptide are as sensitive as    the rheumatoid factor test but with much higher specificity. Additionally anti-CCP2 positivity can predict    future development of RA in both asymptomatic individuals and in patients with undifferentiated    arthritis. It has also been shown    that antibody levels at presentation can correlate with progression to erosive disease.

 

 

 

Click the image to download our brochure 

 

Kit Components:
12 x 8 well breakapart microtitre strips

Reference and positive/negative controls

Sample diluent

6 calibrators

Wash buffer

IgG-HRP conjugate

Substrate

Stop solution.

 

Assay Technology:
The wells of the Axis-Shield anti-CCP microtitre strips are coated with highly-purified synthetic cyclic citrullinated peptides containing modified arginine residues (CCP2). In the quantitative protocol, the antibody concentration in an unknown sample can be estimated by interpolation from a dose response curve based on reference standards. In the qualitative protocol, the response measured in the unknown sample is compared to that of the known concentration reference control.

Performance:
Sensitivity 78%, Specificity 99%

Total Imprecision <11%, Intra-assay imprecision <9%

Linear from 1.04 to 300 U/mL

 

For more information please click here to download our brochure.

 

The assay is also available on Abbott's AxSYM and ARCHITECT platforms and through Bio-Rad's BioPlex 2200 multianalyte system and the Zenit RA system from Menarini. It is also planned for launch on Siemens Centaur analyser and on Beckman Coulter systems 

 

*Products may not be approved for sale in all countries. Please contact us for further details.

Axis-Shield at a Glance

A pioneering organisation focused on the development and manufacturing of important and innovative in vitro diagnostic tests for use in clinical laboratories and at the point of care.

› More about our tests

Focus on Homocysteine

As a general marker of overall health status, few tests carry greater predictive weight than Homocysteine. The amount of Homocysteine in your blood is one of the best independent indicators of how healthy you are.

 

› Axis-Shield Homocysteine assays

© Axis-Shield plc 2011. All rights reserved. Registered in Scotland No. SC145200 - Sitemap | Terms-of-Use | Accessibility | Disclaimer
Luna Place, The Technology Park, Dundee, DD2 1XA, Scotland.
Diagnostics for the laboratory & the point of care in areas of clinical need including diabetes, cardiovascular & neurodegenerative disease, rheumatoid arthritis & infectious disease.